Acute Myeloid Leukemia With Myelodysplasia-Related Changes

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Myeloid Leukemia With Myelodysplasia-Related Changes trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT02727803

Personalized NK Cell Therapy in CBT

This phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in trea…

United States100 participantsStarted 2016-05-19

Treatment: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin

All recent trials (18 shown)

Active — Not RecruitingPhase 2

NCT04231851

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute M…

This is a phase 2 single-arm, open-label clinical trial determining efficacy of CPX-351 in combination with Glasdegib in subjects with Acute Myelogenous Leukemi…

United States30 participantsStarted 2020-02-19

Treatment: Glasdegib, CPX-351

Active — Not RecruitingPhase 1/2

NCT02935361

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leu…

This phase I/II trial studies the side effects and best dose of guadecitabine when given together with atezolizumab and to see how well they work in treating pa…

United States33 participantsStarted 2016-11-02

Treatment: Atezolizumab, Guadecitabine

Acute Myeloid Leukemia With Myelodysplasia-Related Changes

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized NK Cell Therapy in CBT

All recent trials (18 shown)

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute M…

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leu…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized NK Cell Therapy in CBT

All recent trials (18 shown)

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute M…

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leu…

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytar…

Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

VYxeoS Liposomal Italian Observational Study iN the Real Practice

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell…

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients Wi…

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

A Post-Marketing Observational Study of VYXEOS™

Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome,…

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Le…

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer U…

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Tran…

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Fo…